FRONTEO Healthcare, Inc. announced that it will receive ¥500,000,000 in a round of equity funding from existing investor FRONTEO, Inc. (TSE:2158) on January 31, 2017. Out of the total amount, ¥300,000,000 will be contributed to the capital and ¥200,000,000 will be contributed to the capital reserve of the company. Post the closing, the stake of the investor will increase from 89.2% to 99.3%. Post the closing, the capital of the company will increase from ¥27,000,000 to ¥327,000,000. The transaction is expected to close on February 1, 2017.